HPHA.DE XETRA
Heidelberg Pharma AG
1W: -8.9%
1M: -5.2%
3M: -9.6%
YTD: -18.7%
1Y: -48.4%
3Y: -32.1%
5Y: -65.6%
€2.35 ($2.62)
-0.01 (-0.42%)
Weekly Expected Move ±5.3%
€2
€2
€2
€2
€3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$32M
-6.8% ▼
Capital Expenditures
$129K
+71.8% ▲
5Y CAGR: -38.3%
Free Cash Flow
-$32M
-5.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$14M
-3.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$26M | -$20M | -$20M | -$19M | -$42M |
| Depreciation & Amort. | $803K | $757K | $879K | $871K | $3M |
| Stock-Based Comp. | $686K | $554K | $961K | $0 | $0 |
| Change in Working Capital | -$2M | $10M | -$10M | -$12M | $144K |
| Other Non-Cash Items | $494K | -$348K | -$5M | $912K | $7M |
| Operating Cash Flow | -$27M | -$9M | -$34M | -$30M | -$32M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$613K | -$960K | -$478K | -$135K |
| Acquisitions (Net) | -$13K | $15K | $0 | $29K | $0 |
| Investment Purchases | -$13K | $0 | $0 | $0 | $0 |
| Investment Sales | $173K | $0 | $7M | $0 | $0 |
| Other Investing | -$160K | -$13K | $31K | $0 | $0 |
| Investing Cash Flow | -$1M | -$598K | $6M | -$449K | -$135K |
| — Financing Activities — | |||||
| Net Debt Issuance | $10M | $5M | -$10M | -$5M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$851K | -$911K | -$112K | -$106K | -$126K |
| Financing Cash Flow | $29M | $84M | -$10M | $16M | $18M |
| Net Change in Cash | $1M | $75M | -$38M | -$14M | -$14M |
| Cash End of Period | $6M | $81M | $43M | $29M | $15M |
| Free Cash Flow | -$28M | -$9M | -$35M | -$30M | -$32M |